Impact of Cefazolin Shortage on Clinical Outcomes of Adult Patients with Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus in a Tertiary Care University Hospital

Cefazolin is an essential antibiotic used for treating bacteremia; in particular, it is recommended as a first-line agent for infections caused by methicillin-susceptible Staphylococcus aureus (MSSA). In March 2019, problems with a major antibiotic supplier caused a critical shortage of cefazolin in...

Descripción completa

Detalles Bibliográficos
Autores principales: Uda, Atsushi, Onuma, Kenichiro, Shigemura, Katsumi, Kitagawa, Koichi, Yan, Yonmin, Osawa, Kayo, Yano, Ikuko, Miyara, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532967/
https://www.ncbi.nlm.nih.gov/pubmed/34680827
http://dx.doi.org/10.3390/antibiotics10101247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532967/
https://www.ncbi.nlm.nih.gov/pubmed/34680827
http://dx.doi.org/10.3390/antibiotics10101247

Ejemplares similares